Our dedicated Leadership Team is committed to leveraging their extensive expertise and experience in drug discovery and development to bring innovative therapies to patients with glioblastoma and other brain tumors. Team members have developed over a billion dollars in new companies, including other drugs that are currently approved for the treatment of cancer.